PortfoliosLab logoPortfoliosLab logo
NVOH vs. KEMX
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

NVOH vs. KEMX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) and KraneShares MSCI Emerging Markets ex China Index ETF (KEMX). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

NVOH vs. KEMX - Yearly Performance Comparison


Returns By Period

In the year-to-date period, NVOH achieves a -24.75% return, which is significantly lower than KEMX's 10.61% return.


NVOH

1D
-1.00%
1M
0.42%
YTD
-24.75%
6M
-34.28%
1Y
-46.24%
3Y*
5Y*
10Y*

KEMX

1D
1.15%
1M
-8.33%
YTD
10.61%
6M
21.39%
1Y
51.35%
3Y*
20.78%
5Y*
9.30%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


NVOH vs. KEMX - Expense Ratio Comparison

NVOH has a 0.19% expense ratio, which is lower than KEMX's 0.25% expense ratio. Despite the difference, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.


Return for Risk

NVOH vs. KEMX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVOH
NVOH Risk / Return Rank: 11
Overall Rank
NVOH Sharpe Ratio Rank: 11
Sharpe Ratio Rank
NVOH Sortino Ratio Rank: 11
Sortino Ratio Rank
NVOH Omega Ratio Rank: 11
Omega Ratio Rank
NVOH Calmar Ratio Rank: 11
Calmar Ratio Rank
NVOH Martin Ratio Rank: 11
Martin Ratio Rank

KEMX
KEMX Risk / Return Rank: 9393
Overall Rank
KEMX Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
KEMX Sortino Ratio Rank: 9494
Sortino Ratio Rank
KEMX Omega Ratio Rank: 9494
Omega Ratio Rank
KEMX Calmar Ratio Rank: 9191
Calmar Ratio Rank
KEMX Martin Ratio Rank: 9292
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVOH vs. KEMX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) and KraneShares MSCI Emerging Markets ex China Index ETF (KEMX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NVOHKEMXDifference

Sharpe ratio

Return per unit of total volatility

-0.88

2.41

-3.29

Sortino ratio

Return per unit of downside risk

-1.14

3.05

-4.20

Omega ratio

Gain probability vs. loss probability

0.84

1.45

-0.60

Calmar ratio

Return relative to maximum drawdown

-0.89

3.39

-4.28

Martin ratio

Return relative to average drawdown

-1.51

13.94

-15.46

NVOH vs. KEMX - Sharpe Ratio Comparison

The current NVOH Sharpe Ratio is -0.88, which is lower than the KEMX Sharpe Ratio of 2.41. The chart below compares the historical Sharpe Ratios of NVOH and KEMX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


NVOHKEMXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.88

2.41

-3.29

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.53

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.98

0.51

-1.49

Correlation

The correlation between NVOH and KEMX is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

NVOH vs. KEMX - Dividend Comparison

NVOH's dividend yield for the trailing twelve months is around 4.56%, more than KEMX's 2.97% yield.


TTM2025202420232022202120202019
NVOH
Novo Nordisk A/S (B Shares) ADRhedged ETF
4.56%2.38%0.00%0.00%0.00%0.00%0.00%0.00%
KEMX
KraneShares MSCI Emerging Markets ex China Index ETF
2.97%3.28%3.39%2.00%4.10%4.79%1.69%2.77%

Drawdowns

NVOH vs. KEMX - Drawdown Comparison

The maximum NVOH drawdown since its inception was -61.60%, which is greater than KEMX's maximum drawdown of -38.80%. Use the drawdown chart below to compare losses from any high point for NVOH and KEMX.


Loading graphics...

Drawdown Indicators


NVOHKEMXDifference

Max Drawdown

Largest peak-to-trough decline

-61.60%

-38.80%

-22.80%

Max Drawdown (1Y)

Largest decline over 1 year

-53.00%

-15.36%

-37.64%

Max Drawdown (5Y)

Largest decline over 5 years

-30.85%

Current Drawdown

Current decline from peak

-60.40%

-10.66%

-49.74%

Average Drawdown

Average peak-to-trough decline

-36.02%

-9.02%

-27.00%

Ulcer Index

Depth and duration of drawdowns from previous peaks

31.21%

3.73%

+27.48%

Volatility

NVOH vs. KEMX - Volatility Comparison

The current volatility for Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) is 8.19%, while KraneShares MSCI Emerging Markets ex China Index ETF (KEMX) has a volatility of 11.42%. This indicates that NVOH experiences smaller price fluctuations and is considered to be less risky than KEMX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


NVOHKEMXDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.19%

11.42%

-3.23%

Volatility (6M)

Calculated over the trailing 6-month period

37.53%

16.99%

+20.54%

Volatility (1Y)

Calculated over the trailing 1-year period

52.51%

21.41%

+31.10%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

51.04%

17.56%

+33.48%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

51.04%

20.61%

+30.43%